Related Experiment Video
Updated: Mar 17, 2026
10:46
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
4.5K
Aptamers: A Feasible Technology in Cancer Immunotherapy
M M Soldevilla1, H Villanueva1, F Pastor1
1Aptamers Unit, Center for the Applied Medical Research (CIMA), Foundation for the Applied Medical Research (FIMA), Avenida Pío XII No. 55, 31008 Pamplona, Spain.
Journal of Immunology Research
|July 15, 2016
Summary
Aptamers, which are DNA or RNA molecules, offer a promising approach to cancer immunotherapy by modulating immune responses. These molecules can enhance antitumor effects, alone or with other treatments, to improve cancer therapy outcomes.
Area of Science:
- Biotechnology
- Immunology
- Oncology
Background:
- Aptamers are single-stranded DNA or RNA oligonucleotides with specific 3D structures for high-affinity target binding.
- Aptamers offer advantages over antibodies, including chemical synthesis, lower cost, and comparable or superior binding affinities.
- Current cancer treatments face challenges with relapsing cases and significant side effects, necessitating novel therapeutic strategies.
Purpose of the Study:
- To review the benefits of aptamers with immunomodulatory activity in cancer therapy.
- To explore the potential of aptamer-based immunotherapy as a standalone or combination treatment for cancer.
Main Methods:
- Literature review of aptamers used in cancer immunotherapy.
- Analysis of aptamer mechanisms in modulating immune responses against cancer.
- Evaluation of aptamer conjugation strategies for targeted delivery and reduced side effects.
Main Results:
- Aptamers can reliably modulate immune responses by blocking or activating immune receptors.
- Conjugated aptamers can target the immune system, potentially reducing off-target side effects.
- Aptamers demonstrate potential to enhance the therapeutic index and antitumor effects in cancer treatment.
Conclusions:
- Aptamers represent a valuable tool in cancer immunotherapy due to their specificity, cost-effectiveness, and immunomodulatory capabilities.
- Aptamer-based immunotherapy holds promise for improving treatment outcomes, either independently or in conjunction with conventional therapies.
- Further research into aptamer applications could lead to more effective and safer cancer treatments.
Related Concept Videos
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
02:57Targeted Cancer Therapies
1.7K
1.7K
01:30Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
02:53Adaptive Mechanisms in Cancer Cells
7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K